Andrew (Andy) Solomon utilizes his 35+ years of diversified experiences to provide clients in the life sciences and chemical industries the opportunity to achieve an appropriate return on their investment. Andy has spent the majority of his career as an in-house practitioner, handling both intellectual property and commercial matters and utilizes his in-house experience to deliver advice in a straightforward, pragmatic, business-sensitive way. He retired from the Perrigo Company, a leading global generic, store brand and value brand pharmaceutical company, in 2017 and is a registered patent attorney with a chemical background. 

Andy’s practice focuses on:  

• Comprehensive intellectual property, regulatory, and commercial strategies to enable the timely launch of pharmaceutical products
• Intellectual property litigation and inter partes proceedings 
• Intellectual property and regulatory counseling and portfolio development 
• Freedom to operate patent opinions
• Complex licensing agreements
• Commercial agreements 
• Transactional due diligence and agreements
• Litigation settlement agreements

Specific areas of focus include: 

• Hatch Waxman intellectual property and regulatory issues 
• Regulatory approval of pharmaceuticals 
• Review of product labeling for regulatory compliance 
• Acquisitions and divestitures of life science and chemical companies 
• Product development, licensing, distribution and supply agreements 
• Generic, store brand and value brand marketing 
• Formal client education